Documents No. |
Study type (period)
|
Test animals
|
Test facility |
1 |
Technical grade Acute Loxicity (Observation period 14days)
|
Rat |
Imamichi Institute for Animal Reproduction |
〃 |
〃 |
〃 |
2 |
Mouse |
〃 |
〃 |
〃 |
3 |
Rat |
IRDC
|
4 |
Rabbit |
5 |
Rat |
34 |
Rat |
HRC |
6 |
Banvel-D Liquid Acute toxicity (Observation period 14days)
|
Rat |
IRDC |
7 |
Rabbit |
8 |
Rat |
9 |
Mouse |
Safe Pharm Laboratories Ltd. |
10 |
Rat |
28 |
2.5% Granule Acute toxicity (Observation period 14days)
|
Rat |
Safe Pharm Laboratories Ltd. |
29 |
Mouse |
30 |
Rat |
11 |
Tech. Primary eye irritation (21days)
|
Rabbit |
IRDC |
Added-1a
|
Tech. Primary eye irritation (7days)
|
Rabbit |
Wil Research Laboratories, Inc. |
12 |
Banv-D. Primary eye irritation (21days)
|
Rabbit |
IRDC |
31 |
2.5% G. Primary eye irritation (7days)
|
Rabbit |
Safe Pharm Laboratories Ltd. |
13 |
Tech. Primary dermal irritation (72hrs)
|
Rabbit |
IRDC |
Added-2a
|
Tech. Primary dermal irritation (14days)
|
Rabbit |
IRDC |
14 |
Banv-D. Primary dermal irritation (72days)
|
Rabbit |
IRDC |
32 |
25% G. Primary dermal irritation (3days)
|
Rabbit |
Safe Pharm Laboratories Ltd. |
Added-3a
|
Tech. Dermal sensitization |
Guinca pig |
RCC |
15 |
Banv-D. Dermal sensitization |
Guinca pig |
Bio dynamics Inc. |
33 |
2.5% G. Dermal sensitization |
Guinca pig |
Safe Pharm Laboratories Ltd. |
16 |
Subacute (3 months)
|
Rat |
IRDC |
17 |
Chronic (24 months)
|
Rat |
The Kettering Laboratory |
18 |
Chronic (24 months)
|
Dog |
The Kettering Laboratory |
Added-4a
|
Chronic (12 months)
|
Dog |
IRDC |
19 |
Combined (♂26 months) (♀27 months)
|
Rat |
IRDC |
Added-5a
|
Oncogenicity (♂ 89wks) (♀ 104wks)
|
Mouse |
HRC |
20 |
Reproduction (3 generations)
|
Rat |
The Kettering Laboratory |
Added-6a
|
(2 generations) |
Rat |
HRC |
21 |
|
Rabbit |
IRDC |
Added-7a
|
Teratogenicity |
Rabbit |
Argus Research Laboratories, Inc. |
22 |
|
Rat |
ToxiGenics |
23 |
Mutagenicity (Reverse)
|
Salmonella |
The Institute of Environmental Toxicology |
24 |
(DNA Repair) |
Bacillous subtilis |
Added-8a
|
(Reverse) |
Salmonella E. coli
|
SRI International |
(UDS) |
WI-38 cell |
(DNA Repair) |
E. coli B. subtilis
|
25 |
(Chromosomal aberration) |
CHO cell |
MA |
26-(1) |
Pharma-cological (CNS)
|
Mouse |
HRC |
26-(2) |
Pharma-cological (Blood coagulation)
|
Rat |
HRC |
26-(3) |
Pharma-cological (Circulatory, Respiratory)
|
Rat |
HRC |
26-(4) |
Pharma-cological (Skeletal muscles)
|
Mouse |
HRC |